Crotedumab (REGN1193) is a fully human IgG4 моноклональный антитело that binds and inhibits glucagon рецептор (GCGR), with a KD of 0.1 nM. Crotedumab can be used for the research of diabetes.
Crotedumab (REGN1193) is a fully human IgG4 monoclonal antibody that binds and inhibits glucagon receptor (GCGR), with a KD of 0.1 nM. Crotedumab can be used for the research of diabetes.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.